SAMBAI Selects Akoya’s PhenoCycler-Fusion Spatial Proteomics Technology for Large-Scale Cancer Study

SAMBAI Selects Akoya’s PhenoCycler-Fusion Spatial Proteomics Technology for Large-Scale Cancer Study

SAMBAI, a team funded through the Cancer Grand Challenges initiative, reported that Akoya Biosciences’ PhenoCycler®-Fusion system will be the foundational spatial proteomics technology used to generate data for a biobank and data repository for cancer equity research. SAMBAI, which stands for “Societal, Ancestry, Molecular and Biological Analyses of Inequalities,” explained that the objective is to understand the mechanisms and contributions of …